THE EFFECTIVENESS OF A MIXTURE OF BETA-CAROTENE, ALPHA-TOCOPHEROL, GLUTATHIONE, AND ASCORBIC-ACID FOR CANCER PREVENTION

被引:62
作者
SHKLAR, G
SCHWARTZ, J
TRICKLER, D
CHEVERIE, SR
机构
[1] Department of Oral Medicine and Oral Pathology, Harvard School of Dental Medicine, Boston, MA
来源
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL | 1993年 / 20卷 / 02期
关键词
D O I
10.1080/01635589309514281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previous studies have shown that beta-carotene and alpha-tocopherol can act synergistically to inhibit the growth of experimentally induced oral cancer. The initial studies on the synergistic anticancer activity of antioxidants have been extended to include reduced glutathione and ascorbic acid. Sixty male hamsters (4-5 wks old) were divided into six equal groups. Groups 1-6 were treated with 7,12-dimethylbenz[a]anthracene (DMBA) (0.5% solution). Group 2 received a mixture containing equal amounts of beta-carotene, dl-alpha-tocopherol (vitamin E), glutathione, and l-ascorbic acid (vitamin C) (12.5 mug) delivered orally by pipette. Groups 3-6 were treated with beta-carotene alone (50 mug), vitamin E alone (50 mug), glutathione (50 mug) alone, and vitamin C alone (50 mug). Animals were euthanized at 12 and 14 weeks. Tumors were counted and measured, and tumor burden was calculated for each experimental group. The mixture of antioxidants significantly reduced tumor burden, whereas the beta-carotene, vitamin E, and reduced glutathione treatments also reduced tumor burden. Beta-Carotene and glutathione provided greater levels of chemoprevention than vitamin E as single agents. In contrast, vitamin C treatment produced no antitumor effect but increased tumor burden by Week 14. This mixture of antioxidants produced a significant synergistic chemoprevention of oral cancer.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 40 条
[1]   ROLE OF GLUTATHIONE AND OTHER THIOLS IN CELLULAR-RESPONSE TO RADIATION AND DRUGS [J].
BIAGLOW, JE ;
VARNES, ME ;
EPP, ER ;
CLARK, EP ;
TUTTLE, SW ;
HELD, KD .
DRUG METABOLISM REVIEWS, 1989, 20 (01) :1-12
[2]   BETA-CAROTENE - AN UNUSUAL TYPE OF LIPID ANTIOXIDANT [J].
BURTON, GW ;
INGOLD, KU .
SCIENCE, 1984, 224 (4649) :569-573
[3]   THE P53 PROTO-ONCOGENE CAN ACT AS A SUPPRESSOR OF TRANSFORMATION [J].
FINLAY, CA ;
HINDS, PW ;
LEVINE, AJ .
CELL, 1989, 57 (07) :1083-1093
[4]  
Golumbic C., 1941, J AM CHEM SOC, V63, P1279, DOI [10.1021/ja01850a037, DOI 10.1021/JA01850A037]
[5]  
GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243
[6]  
GUSTERSON BA, 1991, ONCOGENE, V6, P1785
[7]  
KUCHAN MJ, 1992, CANCER RES, V52, P1091
[8]  
LANDON JD, 1992, BR J ORAL MAXILLOFAC, V30, P214
[9]  
MCCAY PB, 1985, ANNU REV NUTR, V5, P323, DOI 10.1146/annurev.nu.05.070185.001543
[10]   SERUM BETA-CAROTENE, VITAMIN-A AND VITAMIN-E, SELENIUM, AND THE RISK OF LUNG-CANCER [J].
MENKES, MS ;
COMSTOCK, GW ;
VUILLEUMIER, JP ;
HELSING, KJ ;
RIDER, AA ;
BROOKMEYER, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (20) :1250-1254